Norfolk, VA, April 9, 2021 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive...
Read MoreNorfolk, VA, February 16, 2021 – ReAlta Life Sciences, Inc. (“ReAlta”), a company addressing life-threatening diseases through harnessing the power...
Read MoreNorfolk, VA, December 3, 2020 — ReAlta Life Sciences, Inc., today announced that the European Medicines Agency (EMA) has granted Orphan...
Read MoreNorfolk, VA, November 19, 2020 — Norfolk, Virginia, known globally for its expertise in resilience and strong entrepreneurship ecosystem, is...
Read MoreThe Virginia Pilot | November 16, 2020 https://www.pilotonline.com/inside-business/vp-ib-realta-covid-update-1109-20201116-hkwsno4uencqvbq7tjidj7alva-story.html
Read MoreNorfolk, VA, October 20, 2020 — ReAlta Life Sciences, Inc., today announced the details of a formal ribbon-cutting ceremony at their...
Read MoreNorfolk, VA, July 28, 2020 — ReAlta Life Sciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has...
Read MoreNorfolk, VA, June 29, 2020 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive Officer,...
Read MoreNorfolk, VA, June 02, 2020 — ReAlta Life Sciences is pleased to have received a Commonwealth Research Commercialization Fund (CRCF) grant....
Read More